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Background: Functional brown adipose tissue (BAT), involved in energy expenditure, has recently been detected in
substantial amounts in adults. Formerly overlooked BAT has now become an attractive anti-obesity target.
Methods and results: Molecular characterization of human brown and white adipocytes, using a myriad of techniques
including high-throughput RNA sequencing and functional assays, showed that PAZ6 and SW872 cells exhibit classical
molecular and phenotypic markers of brown and white adipocytes, respectively. However, the pre-adipocyte cell line
SGBS presents a versatile phenotype. A transit expression of classical brown markers such as UCP1 and PPARγ peaked
and declined at day 28 post-differentiation initiation. Conversely, white adipocyte markers, including Tcf21, showed
reciprocal behavior. Interestingly, leptin levels peaked at day 28 whereas the highest adiponectin mRNA levels were
detected at day 14 of differentiation. Phenotypic analysis of the abundance and shape of lipid droplets were consistent
with the molecular patterns. Accordingly, the oxidative capacity of SGBS adipocytes peaked on differentiation day 14
and declined progressively towards differentiation day 28.
Conclusions: Our studies have unveiled a new phenotype of human adipocytes, providing a tool to identify molecular
gene expression patterns and pathways involved in the conversion between white and brown adipocytes.
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Over the last two decades the prevalence of obesity has
reached epidemic levels worldwide. In 2008, studies es-
timated that around 1.5 billion adults had a BMI of
25 kg/m2 or greater, and out of these 205 million men
and 297 million women had a BMI of 30 kg/m2 and
were classified as obese [1]. Secondary major health
risks, such as but not limited to hypertension, insulin
resistance, type 2 diabetes (T2D) and cardiovascular dis-
eases are highly associated with obesity and are seen as
well in increasing numbers of adults worldwide [2,3].
Obesity most commonly results if the energy intake (e.g.
through energy-dense food) exceeds energy expenditure,* Correspondence: loc2008@qatar-med.cornell.edu
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unless otherwise stated.and as a direct consequence the overall energy homeo-
stasis is imbalanced. This excess energy is stored in the
body in form of white fat, [4] which also acts as an endo-
crine organ by releasing adipokines and cytokines into
the bloodstream [5]. The adipocyte-derived hormone
leptin e.g. which regulates energy intake and appetite
was reportedly found at elevated levels in the blood-
stream of obese subjects and is positively correlated
with BMI [6].
While some of the functions and implications of white
adipose tissue (WAT) have been discovered and are in-
vestigated, understanding of the underlying biology is far
from comprehensive or complete. In addition to WAT,
functional BAT in adults has been discovered through
radiological detection by several research groups [7-9]
and has recently become a promising therapeutic target
due to its ability to dissipate energy in form of heat,tral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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(or uncoupled respiration). Surprisingly, only 50 g of
BAT are believed to be sufficient to burn 20% of the
overall average energy intake of a healthy adult [10].
Moreover, some studies propose that the amount of
BAT in humans is inversely associated with BMI, i.e.
healthy, normal-weight subjects bear a greater amount
than obese or overweight individuals [11-13].
Therefore, the idea of enriching BAT or converting
WAT into functional BAT has become attractive and
many efforts have been started to investigate the possi-
bilities further. Promoting BAT-like features in white ad-
ipocytes, known as “browning”, leads to the remodeling
of WAT as energy storage into an energy dissipation site.
Experimental protocols have been pursued that interfere
either with the PPARγ pathway by SirT1-dependent dea-
cetylation [14], or in the p38 mitogen-activated protein
kinase and extracellular signal-related kinase signaling
pathways by a hormone called irisin [15]. It has been
suggested that this “transdifferentiation” could be an in-
herent property of white adipocytes and may not be due
to a distinct cell type with this predisposition [16]. How-
ever, the identification of brown-in-white/brite/beige
adipocytes has led to the assumption that a small pro-
portion of inducible adipocytes is naturally present in
some classical WAT depots [17]. These beige cells can
be induced by cold or β-adrenergic stimulation and can
be observed as UCP1-positive islets [18].
SGBS cells [19] are widely used as a model for white
adipocytes. However, our data suggest that the cell line
harbors an inducible phenotype that changes throughout
the differentiation stage. Day 14 displays multiple charac-
teristics of brown fat cells whereas day 28 represents a ra-
ther white phenotype. Many reports have recently
suggested that the traditional classification of adipocytes
is not exclusive and the existence of beige/brite adipo-
cytes has been shown.
Studies aimed at pinpointing the mechanisms in-
volved in the conversion between white and brown/
beige/brite human adipocytes and metabolic character-
izations are largely dependent on the use of in-vitro cell
systems given the limited access to human subjects and
range of human procedures that can be performed for
obvious ethical reasons.
Thus, we were aiming to elucidate the unique nature
of SGBS cells characterized by displaying transient fea-
tures of brown adipocytes and eventually progressing to
a white phenotype. In depth functional and phenotypic
analysis of differentiated SGBS cells at both distinct
stages and comparison with brown PAZ6 and white
SW872 adipocytes allowed the study of molecular gene
expression patterns and pathways involved in the con-
version between white and brown adipocytes. This
knowledge will be of importance for studies aiming toincrease brown fat depots in order to increase energy




The brown pre-adipocyte cell line PAZ6 was kindly
gifted by Dr. D. Strosberg [20] and SGBS cells were
kindly provided by Dr. M. Wabitsch [19]. SGBS pre-
adipocytes were grown in DMEM/F12 medium supple-
mented with 10% fetal calf serum (FCS), 1.7 mM
panthotenat, 3.3 mM biotin and 1% penicillin/strepto-
mycin (pen-strep). Differentiation was performed at full
confluency. Differentiation medium consisted of DMEM/
F12 supplemented with transferrin (0.01 mg/ml), insulin
(20nM), cortisol (100nM), and triiodothyronine (T3,
0.2 nM). For the initial four days, the differentiation
medium was additionally supplemented with dexametha-
sone (25nM), IBMX (250 μM) and rosiglitazone (2 μM).
PAZ6 pre-adipocytes were cultured in DMEM/F12
medium enriched with 8% FCS, 15 mM Hepes and 1%
pen-strep. At full confluency, differentiation was prop-
agated by addition of 5% FCS, 15 mM Hepes, 33 μM
biotin, 17 μM panthotenat, 1nM T3, 100nM dexa-
methasone, 1 μM rosiglitazone and 1% pen-strep to
DMEM/F12 medium. Additionally, for the initial four
days 0.25 mM IBMX was added to the differentiation
medium.
Human SW872 pre-adipocytes were purchased from
ATCC and cultured in DMEM/F12 medium enriched
with 8% FCS, 15 mM Hepes and 1% pen-strep. At 80 –
100% confluency, oleic acid was added at a final concen-
tration of 100 μM to initiate differentiation.
All culture and differentiation media were changed
every two days and cell cultures were carried out at 37°C
under 5% CO2.
For cold exposure of SGBS cells, we transferred fully
differentiated cells at D14 to an incubator set to 30°C
and 5% CO2 for 4-6 h prior to subsequent RNA isola-
tion. For staining purposes, we kept the culture plates
for additional 10 days until day 14 at 30°C and 5% CO2
after the first four days in 37°C.
RNA isolation and cDNA synthesis
RNA was isolated using Qiagen RNeasy lipid tissue mini
kit and manufacturer’s instructions were followed. The
concentration of obtained total RNA was measured
using Nanodrop reading. 500 ng of RNA was reversely
transcribed in cDNA using GoScript reverse transcript-
ase (Promega).
Quantitative RT-PCR
qPCR reactions were carried out in triplicates on an ABI
7500 cycler using GoTaq qPCR mastermix (Promega).
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reference. Primer sequences are listed in the supplement
(Additional file 1: Table S1).
Western blotting
Cells were lyzed in RIPA buffer and separated by SDS-
PAGE. Immunoblotting was carried out with anti-UCP1
antibodies (Abcam, dilution 1:500) and as loading control
β-actin protein levels were assessed (Abcam, dilution
1:2500). Secondary horseradish-peroxidase-conjugated
anti-mouse antibodies were purchased from Sigma and
used at a dilution of 1:5000.
RNAsequencing
Total RNA was isolated with the RNeasy lipid tissue mini
kit (Qiagen) and the manufacturer’s instructions were
followed. Purified total RNA was subjected to deep sequen-
cing analysis. Initially, isolated RNA was quantified using
Agilent Bioanalyzer 2100 with the RNA integrity number
greater than 8.0 before Illumina Genome Analyzer (GA)
sequencing. RNA sequencing (RNAseq) was performed
using the Illumina Genome Analyzer to measure mRNA
expression levels from seven human cell line samples. Typ-
ically, 2–4 ug total RNA were used in library construction.
Total RNA was reverse transcribed to double-stranded
cDNA, digested with NlaIII and ligated to an Illumina
specific adapter containing a recognition site of MmeI.
Following MmeI digestion, a second Illumina adapter, con-
taining a 2-bp degenerate 3’ overhang was ligated. The
obtained sequences were aligned onto human RefSeq data-
base (ftp://ftp.ncbi.nih.gov/refseq) using SOAP software
[21]. Only uniquely mapped sequences to RefSeq genes
were kept for subsequent analysis. For each mRNA sample,
we generated on average a total 26 M raw reads. On aver-
age, 84% of the reads matched known genes, and ~16,000
genes had expression level data. Raw data are publicly
available through the NCBI GEO database [GSE63190].
Gene expression analysis
Gene expression values were summed from normalized
RNAseq reads. Hierarchical clustering of gene expression
was based on Speerman rank correlation coefficient be-
tween gene expression values of each of the three cell lines
using complete linkage for agglomeration. As an approach
to identify differentially expressed genes (DEGs), we ap-
plied the classical single t-test.
Gene ontology analysis
Gene ontology (GO) enrichment analysis provides all GO
terms that are significantly enriched in a list of DEGs by
aligning GO terms to the database (http://www.geneonto-
logy.org/) and KEGG pathways (http://www.genome.jp/
kegg/). Lists of differentially expressed genes were clus-
tered and calculate by Cluster and Java Treeview software.Transcripts, which had missing values in at least one ex-
periment, were removed from the analysis. Pathway and
gene interaction analysis was performed with Ingenuity
Pathway analysis software.Oil Red staining
Adherent pre-adipocytes and differentiated adipocytes
were fixed with 4% paraformaldehyde for 30 min at room
temperature (RT). After one washing step with PBS, cell
layers were washed with 60% isopropanol once. Oil Red
solution was added for 5 min at RT and rinsed off with
diH20 until clear. Stained adipocytes were assessed under
a light microscope and images were analyzed using Adobe
Photoshop software.Immunofluorescence microscopy
For UCP1 staining, adherent pre-adipocytes and differenti-
ated adipocytes were cultured in glass bottom slides and
fixed with 4% paraformaldehyde for 30 min at RT. Next,
cells were blocked with 2% BSA for one hour in order to
prevent unspecific binding and incubated overnight with
anti-UCP1 antibody (Abcam, diluted 1:250) at 4°C. Second-
ary antibody incubation was carried out in the dark at RT
for one hour with anti-mouse Alexa 647 (Life technologies,
diluted 1:500) and in the presence of Mitotracker (Life
technologies, 10nM final concentration).
For lipidtox stainings of the lipid droplets, cells were fixed
with 4% paraformaldehyde for 30 min at RT. After one
washing step with PBS, cells were co-stained with Lipidtox
red (Invitrogen, diluted 1:200) and Mitotracker green (Life
technologies, 10nM final concentration) for 30 min in the
dark at 37°C.
Nuclei were stained using BlueNuc stain (Life technolo-
gies). Cell monolayers were examined using a digital EVOS
f1 microscope equipped with an AMG camera. Digital im-
ages were processed with Photoshop CS6 (Adobe Systems,
CA, USA).Expression of mitochondrial respiratory complexes I, II, III,
IV and V
The mitochondrial respiratory complexes analysis was
performed using the Human Oxidative Phosphorylation
(OXPHOS) Magnetic Bead Panel (Cat. # H0XPSMAG-16K,
EMD Millipore, Massachusetts, USA). The immunoassay
was carried out in duplicates according to the manufacturer
instructions, using antibody-coated fluorescent beads.
Antigen bound beads were quantified in the Luminex
200 instrument. Complexes I, II, III, IV and V fluorescent
units (FU) were normalized to the nucleus-encoded
mitochondrial protein nicotinamide nucleotide transhy-
drogenase (NNT).
Figure 1 (See legend on next page.)
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Figure 1 Human brown PAZ6 adipocytes accumulate multiple small lipid droplets upon differentiation and express peri-nuclear and cytoplasmatic UCP1
at high levels. PAZ6 cells were differentiated for 14 days and cell monolayers were stained and examined by microscopy. (a) Oil Red staining was carried
out as described above and the presence of stained lipid droplets at D7 (left) and D14 (right) was assessed at a magnification of 20×. (b and c) Premature
and differentiated PAZ6 cells were co-stained with mitotracker (green) to test the abundance of mitochondria, lipidtox (red, in b) for neutral lipid droplets
or anti-UCP1 antibodies (red, in c) and DAPI (blue) to visualize nuclei. Single-channel images were overlayed and processed by Photoshop software. All
scale bars are reported.
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SGBS and SW872 cells using the Sea horse XF flux
analyzer
Oxygen consumption rate (OCR) and extracellular acidifi-
cation rate (ECAR) from PAZ6 and SGBS adipocytes were
measured using the SeaHorse flux analyzer XF96 (Sea-
horse Biosciences, North Billerica, MA). The PAZ6 or
SGBS pre-adipocytes were plated on SeaHorse cell culture
plates at 5x104 cells/well to achieve confluence and differ-
entiated for 14 or 28 days. Prior to the assay, the growing
media was replaced by unbuffered DMEM containing
2.5 mM glucose and 5 mM pyruvate (Gibco #12800-017,
pH = 7.4 at 37 C). Fatty acids (100 μM) were added in
some cases, where indicated.
Basal, uncoupled and maximal respiration rates were
calculated upon subtraction of the non-mitochondrial
oxygen consumption obtained at the end of each assay by
the addition of rotenone (4 μM) and myxothiazol (1 μM).
ECAR, indicative of glycolytic capacity was also obtained.Figure 2 Differentiated PAZ6 cells overexpress adipokines and brown
adipocyte markers. PAZ6 cells were cultured in monolayers and
differentiated for 14 days. RNA was isolated using the Qiagen lipid
tissue mini kit and cDNA synthesis was carried out. Quantitative real-
time PCR was performed by SYBR green detection method and values
are reported as RQ normalized referring to the relative quantification
compared to HPRT expression and normalized for D0 baseline expression
levels for each gene. All experiments were done in triplicates and data
are derived from at least three independent experiments. (* p <0.01,
** p < 0.001).Statistical analysis
The data presented in the line and column charts are
the mean ± SEM from multiple determinations. Data ana-
lysis was carried out in Prism 6 (Graph Pad). Statistical
significance was determined by t-tests for comparisons be-
tween pre-adipocytes versus mature adipocytes and 2-way
ANOVA followed by Tukey multiple comparisons test for
all other comparisons including 3 groups or more.
Results
Comparative analysis of three human adipocyte cell lines
The unique human brown adipocyte cell line PAZ6
accumulates multiple small lipid droplets upon
differentiation and expresses peri-nuclear and cytoplasmatic
UCP1 at high levels
We first characterized both undifferentiated and differen-
tiated human PAZ6 adipocytes and we conducted Oil Red
and fluorescence staining experiments of fixed cells,
grown in monolayers. Images of PAZ6 were taken on Day
0 (D0), D7 and D14. Initial lipid droplet formation was
visible seven days after differentiation initiation and the
presence of neutral lipids was confirmed by Oil Red
(Figure 1a) and Lipidtox (Figure 1b) staining. Notably,
as expected, multiple small lipid droplets consistent with
their brown adipocyte phenotype were observed in mature
PAZ6 cells. In addition, staining with anti-UCP1 antibody
revealed increasing expression of UCP1 protein during
the maturation process of PAZ6 cells until D14 (Figure 1c).
Co-staining with Mitotracker dye revealed abundance of
mitochondria along with the increased expression of
UCP-1 in differentiated PAZ6 adipocytes as compared to
PAZ6 pre-adipocytes (Figure 1b and c). This confirmed
co-localization of UCP1 and mitochondria.
Next, we assessed the molecular expression levels of adi-
pocyte markers in pre-mature and differentiated human
PAZ6 cells by quantitative real-time RT-PCR. As expected,
known brown adipocyte markers such as PGC1α,
PRDM16, PPARγ and beta3-adrenergic receptor (b3AR)
were found to be up-regulated at D14 after initiating the
differentiation process (Figure 2). Importantly, up-
regulation of the BAT-defining marker UCP1 was con-
firmed and consistent with immunofluorescent detection
as shown in Figure 1c. In addition, common adipocyte
markers such as leptin, adiponectin and perilipin were
highly up-regulated in mature PAZ6 cells and underlined
the formation and presence of neutral lipid droplets.
Figure 3 Differentiated SW872 adipocytes depict a high abundance of lipid droplets but no UCP1 expression. (a) Oil Red staining was carried out as
described above and the presence of stained lipid droplets at D7 was assessed at a magnification of 20×. (b and c) Premature and differentiated SW872
cells were co-stained with mitotracker (green) to test the abundance of mitochondria, lipidtox (red, in b) for neutral lipid droplets or anti-UCP1 antibodies
(red, in c) and DAPI (blue) to visualize nuclei. Single-channel images were overlayed and processed by Photoshop software. All scale bars are reported.
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of lipid droplets but no UCP1 expression
We then assessed the differentiation potential of SW872
adipocytes by observing the formation of lipid droplets.
Interestingly, as opposed to PAZ6 and SGBS cells, 100% of
SW872 were differentiated after 7 days of culture and the
phenotype did not differ from the one observed at D14. We
therefore considered D7 as the final stage of differentiation
in SW872 cells and performed subsequent experiments at
D7. We confirmed full differentiation by Oil Red (Figure 3a)
and fluorescence staining with Lipidtox (Figure 3b). In
addition, as shown in Figure 3c, we performed staining withanti-UCP1 antibodies. We did not, however, detect expres-
sion of UCP1 in fully differentiated SW872 cells at D7 and
no remarkable increase in the abundance of mitochondria
from D0 to D7 was observed, as reflected by mitotracker
staining (Figure 3b and c).
Human SGBS adipocytes display features of white and
brown adipocytes, respectively in a time-dependent manner
Lastly, we cultured and differentiated SGBS adipocytes up
to D14 and observed the formation, abundance and size of
lipid droplets. We noted a rather brownish phenotype of
mature SGBS cells as characterized by multiple small lipid
Figure 4 (See legend on next page.)
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Figure 4 Human SGBS adipocytes display features of white and brown adipocytes respectively. (a) Oil Red staining was carried out as described above
and the presence of stained lipid droplets at D14, D21 and D28 was assessed at a magnification of 20×. (b and c) Premature and differentiated SGBS cells
were co-stained with mitotracker (green) to test the abundance of mitochondria, lipidtox (red, in b) for neutral lipid droplets or anti-UCP1 antibodies (red,
in c) and DAPI (blue) to visualize nuclei. Single-channel images were overlayed and processed by Photoshop software. All scale bars are reported.
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two weeks up to D28. Interestingly, and to our surprise,
the size and number of lipid droplets changed over the
course of four weeks as shown in Figure 4a and b. D14 as
initially mentioned was represented by multiple small lipid
droplets which increased remarkably in size, decreased
proportionally in number up to D28 and exemplified a ma-
ture white adipocyte phenotype.
Further elucidation of the versatile, inducible phenotype
of human SGBS cells
We confirmed the findings derived from Oil Red staining
in SGBS cells by lipidtox fluorescent imaging and detected
remarkable changes in lipid droplet size and number as
shown before (Figure 4b). We then tested the expression
levels of UCP1 protein in order to comprehend whether
D14 truly represented a rather brown and D28 a white
adipocyte phenotype. Immunofluorescent images revealed
a peak in UCP1 expression at D14 and a decline up to
D28 (Figure 4c). Notable changes in the abundance of
mitochondria could not be seen and expression levels of
mitochondrial protein stained by mitotracker were con-
stant (Figure 4b and c).
Molecular analysis of adipokines expression in
undifferentiated and mature SGBS cells confirms phenotypic
findings
In order to get deeper insight into the molecular expression
levels of key molecules we performed quantitative RT-PCR.
The expression levels of brown adipocyte markers, such as
UCP1, PGC1α and PPARγ decreased on D28 after peaking
at D14 (PPARγ or UCP1) or D21 (PGC1α). PRDM16 and
b3AR expression levels were similar in their expression pat-
tern with a low level at D21 and comparable expression
levels at D14 and D28 (Figure 5). Interestingly, key markers
of white adipocyte markers such as Hoxc9, Tcf21 or the
pan-adipocyte marker leptin displayed increasing expres-
sion level on the course of 4 weeks and peaked at D28
(Figure 5). Lastly, a highly significant down-regulation of
adiponectin from D14 to D28 was observed (Figure 5).
Direct comparison of UCP1 protein levels of PAZ6 and SGBS
adipocytes confirms the transient BAT-like phenotype of
SGBS cells
To determine protein levels of UCP1 in SGBS adipocytes
we directly compared D14 and D28 samples with differen-
tiated PAZ6 cells. Interestingly, UCP1 protein content in
SGBS cells peaked at D14 and was comparable or slightlyabove levels detected in mature PAZ6 adipocytes (Figure 6).
The abundance of UCP1 protein declined in SGBS adipo-
cytes up to D28 as seen by immunofluorescence imaging
(Figure 4) and measured on the mRNA level by quantita-
tive RT-PCR (Figure 5). Two cancer stem cells samples,
namely C4-2 and LNCaP, are shown as positive control of
UCP1 expression as Valle et al. recently reported its abun-
dance in several types of cancer [22].
Next-generation deep sequencing of three human
adipocytes reveals pathways involved in the molecular and
phenotype-switch observed in SGBS cells
To further elucidate the involvement of molecular path-
ways and molecules involved in the observed conversion of
SGBS adipocyte from a brownish stage at D14 to a more
WAT-like phenotype on D28 we performed next-
generation RNAsequencing. SW872 cells were assessed at
D0 and D7, PAZ6 adipocytes at D0 and D14 and lastly,
SGBS cells were sequenced at D0, D14 and D28. Compre-
hensive bioinformatics analysis was performed which
revealed 485 DEGs between the SGBS D14 and D28 sam-
ple with fold change >2 and FDR <0.001. Out of those
transcripts 272 were found to be up-regulated and 213 were
down-regulated at D28. We queried differentially expressed
genes against known pathways by gene ontology analysis
and the top 10 involved pathways are shown in Figure 7a.
Interestingly, the pathway mostly affected by the phenotypic
changes seen in differentiated SGBS cell is the PPARγ path-
way followed by the adipocytokine signaling pathway. As
shown in Figure 7b, many transcripts including UCP1 are
down-regulated in SGBS D28 when compared to D14 sug-
gesting derogated PPARγ signaling. In addition, the second
most affected pathway is adipocytokine signaling (Figure 7a
and b). Interestingly, though this pathway is involved in all
types of adipocyte signaling and not specific for brown adi-
pocytes, we observed a particular down-regulation of PGC1
α whilst leptin remained up-regulated. Taken together, these
findings illustrate that key markers for BAT such as UCP1
and PGC1α are down-regulated in SGBS cells at D28 while
no general affect on lipid metabolism was observed as seen
by up-regulated leptin levels.
We then plotted the expression values for DEGs identi-
fied by comparing SGBS D14 with D28 along with the un-
differentiated and differentiated samples of PAZ6 and
SW872, respectively. Clustering analysis based on centered
correlation was performed for the remaining 284 transcripts
and data were displayed with Treeview software (Figure 7c).
Interestingly, SGBS D14 and PAZ6 D14 samples clustered
Figure 5 Molecular analysis of adipokine expression in undifferentiated and mature SGBS cells confirms phenotypic findings. SGBS cells were cultured in
monolayers and upon reaching confluency, cells were differentiated for 28 days. RNA was isolated using the Qiagen lipid tissue mini kit and cDNA synthesis
was carried out. Quantitative real-time PCR was performed by SYBR green detection method and values are reported as RQ normalized referring to the
relative quantification compared to HPRT expression and normalized for D0 baseline expression levels for each gene. All experiments were done in
triplicates and data are derived from at least three independent experiments. (a) Gene expression of markers of brown adipocytes and general fat cell
markers were assessed. (b) In order to elucidate the versatile phenotype of SGBS cells, expression levels of white adipocyte markers were tested. All
experiments were done in triplicates and data are derived from at least three independent experiments. (* p <0.01, ** p < 0.001).
Guennoun et al. Journal of Translational Medicine  (2015) 13:135 Page 9 of 18together suggesting common gene expression patterns.
SGBS and PAZ6 pre-adipocytes formed another cluster as
well as differentiated SW872, which clustered along with
their undifferentiated counterpart. Further analysis of asmall subset of genes, which is exclusively shared between
SGBS D14 and PAZ14 samples (blue boxes, Figure 7c) is
depicted in Figure 7d, and shown as a headmap image
(upper panel). We subjected the 41 genes to pathway
Figure 6 UCP1 protein levels in SGBS adipocytes peak at Day 14 and
are comparable to levels detected in differentiated PAZ6 cells. Lysates of
SGBS and PAZ6 cells were prepared at D0, D14 and D28 (SGBS only) and
immunoblotted with antibodies against UCP1. Equal protein loading was
confirmed with antibodies against β-actin. CSC-C4-2 and CSC-LNCaP
lysates are shown as positive control. CSC = cancer stem cells.
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PPARγ as the top upstream regulator, which is significantly
inhibited in SGBS D28, compared to SGBS D14 cells (p
value 1.33E-28) along with nine downstream targets
(namely ApoE, SCD, GPAM, PLIN1, FASN, AGPAT2,
DGAT2, LIPE and NR1H3) which are shown in Figure 7d,
lower panel.
Quantification of mitochondrial respiration rates of the
PAZ6, SGBS and SW872 cell lines at different stages of
differentiation
We have used the Luminex technology to obtain the rela-
tive expression of the mitochondrial respiratory complexes
I, II, III, IV and V proteins and the SeaHorse XF24 and
XF96 Flux analyzers to assess oxygen consumption and
glycolysis in the three cell lines.
Differentiation of PAZ6, SGBS and SW872 promoted
an overall induction of respiratory complex proteins
relative to the nuclear-encoded protein NNT (Figures 8a,
9a and 10a). In line with this increase in respiratory
complex proteins expression, the oxidative metabolic
capacity was increased in the adipocyte relative to the pre-
adipocyte state in all three lines. A robust raise in State3u,
FCCP-dependent respiration was observed as a result
of PAZ6 differentiation (Figure 8b). Basal, uncoupled
and maximal respiratory capacity, obtained after rotenone/
myxothiazol-dependent non-mitochondrial respiration were
higher in the differentiated PAZ6 cells compared to
their undifferentiated counterparts (Figure 8c), Twenty-
four hours treatment with a retinoic acid (RA), T3 or RA,
T3 and forskolin/IBMX (FI) cocktail further induced com-
plexes II, III and IV (Figure 8d) and increased the maximal
respiratory capacity of PAZ6 adipocytes (Figure 8e).
Notably, this combined treatment also significantly pro-
moted a raise in the rate of extracellular acidification ofPAZ6 adipocytes, indicating an increase in glycolytic cap-
acity (Figure 8f). The induction of glycolysis by RA, T3 and
FI combined was higher than the induction observed upon
RA treatment alone or in combination with T3 only
(Figure 8f).
In SGBS cells, the induction of mitochondrial respira-
tory proteins and oxidative capacity in adipocytes required
rosiglitazone and was dependent on differentiation length
(Figure 9a). Whereas complex I had comparable levels of
expression at D14 and D28 in the presence of rosiglita-
zone, complex III was higher at D28 while complex V was
higher at D14 (Figure 9a). State 3u, FCCP-dependent res-
piration peaked at D14 although it still remained elevated
at D28 relative to the undifferentiated cells (Figure 9b).
Calculated basal and maximal respiration were the highest
at D14 (Figure 9c).
In SW872 cells, the increase in respiratory complexes
was observed for all five complexes in the differentiated ad-
ipocytes (Figure 10a). This increase was accompanied by a
matching increase in State 3u, FCCP-dependent maximal
oxidative capacity in the differentiated compared to the
undifferentiated state. RA alone promoted an additional
increased in maximal respiratory capacity (Figure 10b)
and forskolin/IBMX did not synergize with RA in
improving respiration but instead trended towards sup-
pressing it (Figure 10c).
Cold exposure of SGBS adipocytes activates BAT markers
and leads to an enhanced brown adipocyte phenotype
Lastly, we explored the capacity of SGBS cells to respond
to cold cell-autonomously (in a β-adrenergic-independent
manner) to see whether the brownish phenotype seen at
D14 can be further enhanced. Indeed, we noticed an in-
crease in lipid droplet number and decrease in droplet size
when SGBS cells were cultured at 30°C for 10 days fol-
lowing initial differentiation at 37°C for four days and
compared to the control cells which were kept entirely
at 37°C (Figure 11a and b). This finding was observed
through Oil Red staining (Figure 11a), and by fluorescence
staining of lipid droplets (Figure 11b) and UCP1 expression
(Figure 11c). Of note, UCP1 expression and mitotracker
co-staining were elevated in the cold-exposed SGBS cells
and underlined the inducible brown phenotype. We further
assessed the molecular expression level of known adipocyte
markers of SGBS cells that were transferred to 30°C for 6 h
compared to control cells at D14. Notably, expression
levels of UCP1, PPARγ, PRDM16 were significantly in-
creased in cells exposed to a cold environment wheras no
further increase in the expression of WAT markes such as
Tcf21 and Hoxc9 were found (Figure 11c).
Discussion
It is common wisdom that obesity and its associated meta-
bolic and inflammatory complications have become one of
Figure 7 (See legend on next page.)
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Figure 7 Next-generation whole genome RNA sequencing elucidates the activation of key pathways in three human adipocytes upon differentiation.
RNA was isolated as described above and subjected to next generation sequencing analysis. Comparison of SGBS cells at D14 and D28 revealed 485 DEGs
with fold change >2 and FDR <0.001. Genes were queried against know annotation databases and gene ontology analysis was performed. (a) 10 top-
involved pathways are shown; among those PPARγ and adipocytokine signaling are the two most significantly involved pathways (b). (c) Expression levels
of 284 DEGs with no absence calls between SGBS S14 and D28 samples were clustered for all three human adipocytes and visualized by Treeview software.
Two clusters highlighted in blue are characteristic for SGBS D14, representative of the brownish stage, and differentiated, brown PAZ6 cells on D14. (d) 41
DEGs are displayed separately using Treeview software (upper panel). PPARγ gene interaction networks were generated with Ingenuity Pathway analysis
software (lower panel). Log2 ratios are reported based on the comparison between SGBS D14 vs. SBGS D28.
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financial burden to modern societies worldwide [23,24].
The lack of efficient treatment options available to the
medical community urgently calls for scientists to bring
meaningful and innovative ways to combat this pandemic.
The in-depth understanding of the biology of adipose tis-
sues is a critical piece to solving this obesity puzzle. Beyond
its originally defined fat storage function, adipose tissue
exhibits endocrine gland-like functions, secreting media-
tors that exert behavioral, metabolic and inflammatory
actions at distant organs. Its non-parenchymal cells con-
tribute to the synthesis of immune mediators with pro-
inflammatory properties [25]. Furthermore, the highly
specialized brown adipose sub-type displays the intrinsic
ability to generate heat through a process called non-
shivering thermogenesis (NST), which confers mammals
the ability to maintain body temperature constant des-
pite that of the environment [26]. Due to its substantial
caloric cost, NST has begun to be explored therapeutic-
ally in the past seven years [26]. It is believed that NST
can be beneficial in the overweight or obese scenarios, by
counteracting the excessive energy and fat deposition
which constitute the main risk factors for cardiovascular
disease, T2D, chronic inflammation and cancers.
Though adipose tissue can be studied in vivo, the inte-
grative nature of metabolism complicates the understand-
ing of the specific role it plays in the whole animal. Each
time a new genotype or compound effects is tested, most
metabolic parameters are gathered at defined endpoints so
the phenotypes or drug-effects observed reflect the sum of
the role played by all tissues combined. This is an ex-
tremely valuable approach and a key step in the drug de-
velopment pipeline. Nevertheless, complementing such
in vivo findings with studies in cell models allows for the
delineation of the cellular mechanisms behind the effects
of the genetic and chemical interventions in question upon
the whole animal biology. In vitro studies obviously also
allow for much quicker and less costly preliminary testing
that can unravel drug and protein targets to be pursued.
With this in mind, we were prompted to extend the
characterization of the unique immortalized human pre-
brown adipocyte cell line PAZ6 [27], aiming that its full
potential can be utilized in metabolic research. Further-
more, we have paralleled our study of PAZ6 cells with thatof two other human pre-adipocytes cells lines, the SGBS
and the SW872 cells, in order to cover the broad spectrum
of adipocyte phenotypes, which ultimately impact meta-
bolic outcomes.
A few other strains of human white adipocytes, whose
characterization is beyond the scope of this study, are
available. The LiSa-2 [28], LS-14 [29] and AML-1 [30] cell
lines have originated from spontaneous tumors and the
Chub-S7 line was immortalized by means of telomerase
reverse transcriptase and papillomavirus E7 oncoprotein
transformation [31]. With regards to brown pre- or adipo-
cyte cell lines, there are no other immortalized human cell
lines to our knowledge. However, human multipotent
adipose-derived stem cells (MADS) that have the potential
to differentiate in either white or brown fat adipocytes
have been established in culture [32]. Additionally, SVF
from supra-clavicular fat [33] and primary stem cells [34]
have also been utilized in studies of human brown adipose
in vitro. A comparison between the PAZ6 features and
those of MADS should be informative in the future.
By extensively comparing and characterizing three hu-
man adipocyte cell lines we noticed that the SGBS cell line
harbors a versatile phenotype, which changes throughout
its mature stage and questions the characterization of
SGBS as a true white adipocyte cell line model. D14 dis-
plays multiple characteristics of brown fat cells such as
UCP1 and PPARγ overexpression whereas D28 represents
a rather white phenotype.
Jo et al. previously reported the existence of a temporary
increase of PPARγ and transient expression of UCP1 in
the stromal-vascular fraction of adipose-derived stem cells
(ADSCs), which were induced to differentiate [35]. We
also considered the possibility that the induction of
brown-adipocyte-like features upon differentiation in cell
line settings was induced artificially since some studies re-
ported that chronic treatment of white adipocytes with the
peroxisome proliferator-activated receptor γ agonist rosi-
glitazone promotes PGC1α and UCP1 expression along
with an increase in mitochondriogenesis [36]. In our
study, PAZ6 and SGBS differentiation media were also
enriched with rosiglitazone, as this is a standard formula-
tion and widely used. We therefore depleted rosiglitazone
from the SGBS medium to investigate whether our obser-
vation was mainly attributed to its presence. Nevertheless,
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regulation of BAT markers such as UCP1 and
PPARγ in SGBS cells at D14, which then declined
up to D28 (data not shown). We therefore con-
clude that we are not promoting the phenotype ob-
served in maturating SGBS cells by drug treatment,
but rather are seeing an intrinsic property of the
SGBS adipocyte cell line itself.Figure 8 (See legend on next page.)The third cell line, which we characterized, was
SW872. Even though SW872 cells are widely used as a
human pre-adipocyte model [37] some features are
not fully characteristic for WAT. We noticed that the
differentiation of SW872 cells could be initiated at
confluency levels less than 100% which was indeed re-
quired for PAZ6 and SGBS cells. Similarly, we
observed that 100% of SW872 cells were fully
(See figure on previous page.)
Figure 8 Metabolic characterization of undifferentiated and differentiated PAZ6 cells. (a) Expression of mitochondrial respiratory complexes I, II, III, IV and
V in PAZ6 pre-adipocytes and adipocytes. Differentiation is associated with an overall increase in the expression of mitochondrial electron transfer chain
complexes. Treatment of PAZ6 adipocytes with retinoic acid (1 μM), T3 (2nM) and Forskolin (2 μM)/IBMX (125 μM) further increases the expression of
complexes II, III and IV. Values are presented as the fluorescent units ratio between each respiratory complex protein and the nuclear encoded
NNT protein ± SEM. (b) OCR of PAZ6 pre-adipocytes and adipocytes in unbuffered DMEM containing 5 mM pyruvate and 2.5 mM glucose. (c) Basal,
uncoupled and maximal respiratory capacities are robustly increased in the adipocyte relative to the pre-adipocyte state (* p < 0.0001). (d) OCR in PAZ6
adipocytes under various treatments (24 hrs).. FCCP-dependent (State3u) respiration is mildly increased in adipocytes treated with retinoic-acid (RA) plus
T3 (**p < 0.05 vs. adipocyte). Forskolin/IBMX had a synergistic effect upon State3u respiration when given in combination with RA (***p < 0.0001
vs. adipocyte; # p < 0.05 vs. adipocyte + RA). (e) Basal, uncoupled and maximal respiration were calculated. Maximal respiratory capacity is increased in
adipocytes treated with RA plus T3 (*p < 0.05 vs. adipocyte) and RA plus T3 plus forskolin/IBMX (**p < 0.05 vs. adipocyte). (f) Glycolysis, shown as the rate
of extracellular acidification (ECAR) in PAZ6 pre-adipocytes and adipocytes under several conditions. Rates are significantly increased in adipocytes treated
with RA, RA plus T3 (**p < 0.01 vs. adipocyte) and RA plus T3 plus forskolin/IBMX (***p < 0.001 vs. adipocyte). Results expressed as mean ± SEM.
Figure 9 Metabolic characterization of undifferentiated and differentiated SGBS cells. Where noted rosiglitazone (rosi) was added during the first
initial days of differentiation at a final concentration of 2 μM. (a) SGBS respiratory complexes expression. An overall increase in expression results
from differentiation in the presence of rosiglitazone (*p < 0.02). Values are presented as the fluorescent units ratio between each respiratory complex
protein and the nuclear encoded NNT protein ± SEM. (b) Oxygen consumption rate (OCR) by SGBS pre-adipocytes and adipocytes in unbuffered DMEM
containing 5 mM pyruvate and 2.5 mM glucose. Basal and FCCP-dependent State3u respiration peaked at D14 in a rosi-dependent manner. (c)
Basal, uncoupled and maximal respiration are shown. Basal respiration is increased in adipocytes at D14 in the presence of rosi (*p < 0.05 vs. adipocyte
D14 – rosi; & p < 0.01 vs. pre-adipocyte). Maximal respiratory capacity is increased in the adipocytes differentiated in the presence of rosi at D14 and D28
(*** p < 0.0001 vs. pre-adipocyte, # p <0.0001 vs. adipocyte D14 or D28– rosi; @ p < 0.0001 vs adipocyte D28 + rosi). Results are expressed as mean ± SEM.
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Figure 10 Metabolic characterization of undifferentiated and differentiated SW872 cells. (a) SW872 respiratory complexes expression. Differentiation in
oleate increases the expression of the mitochondrial respiratory complexes. Values are presented as the fluorescent units ratio between each respiratory
complex protein and the nuclear encoded NNT protein ± SEM. (b) OCR by SW872 pre-adipocytes and adipocytes in unbuffered DMEM containing 5 mM
pyruvate and 2.5 mM glucose. Basal and FCCP-dependent State3u respiration are increased in the RA-treated adipocyte relative to the pre-adipocyte state
(** p < 0.001; ***p <0.0001 versus pre-adipocyte; # p <0.05 vs. adipocyte + RA + T3 + forskolin/IBMX)). (c) Basal, uncoupled and maximal respiration are
calculated. RA increased the maximal respiratory capacity of the adipocytes relative to the pre-adipocytes (*p < 0.05). Results expressed as mean ± SEM.
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ture conditions. Additionally, SW872 cells continued to
proliferate even during the differentiation process and did
not undergo contact inhibition and growth arrest (data
not shown). Of special note, we observed that differenti-
ated SW872 adipocytes displayed many characteristics of
WAT, however especially lipid droplet size and numbers
were not characteristic for the white adipocyte phenotype.
In addition to the up-regulation of characteristic BAT
markers in SGBS and PAZ6 cells, we noticed high levels of
adiponectin in mature PAZ6 and SGBS cells at D14. Not-
ably in line with the transient phenotype, adiponectin levels
in SGBS cells decrease up to D28 by 50% as opposed to
leptin levels. Interestingly, adiponectin is known for its
anti-inflammatory properties and inverse correlation to in-
sulin resistance and its levels in humans rise in response to
weight loss and exercise [38-40]. Next generation sequen-
cing revealed that 5 out of the top 10 pathways, which aredifferentially expressed between SGBS cells at D14 and
D28, are involved in adipogenesis and/or metabolism.
Among them the PPARγ pathway followed by the adipocy-
tokine signaling pathway are most significantly affected.
PPARγ is a member of the nuclear receptor superfamily of
ligand-inducible transcription factors which control the ex-
pression of genes mainly involved in adipogenesis, lipid
metabolism, inflammation and maintenance of metabolic
homeostasis. Interestingly, PPARγ signaling was signifi-
cantly and exclusively up-regulated in PAZ6 and SGBS
cells at Day 14, but underwent inhibition in SGBS cells cul-
tured to D28. Furthermore, many downstream molecules
such as UCP1 were down-regulated in SGBS cells at D28,
which indicates the shift from the brown to the white
phenotype. Interestingly, Perilipin 1 (PLIN1) was also
among the genes down-regulated in SGBS cells at D28. A
recent study from Sawada et al. revealed that overexpres-
sion on PLIN1 lead to an induction of a brown-like or
Figure 11 Cold exposure of SGBS adipocytes activates BAT markers and leads to an enhanced brown adipocyte phenotype. SGBS cells were
cultured at 30°C for either 10 days or 4-6 h and objected to phenotypic or molecular assessment of BAT and WAT markers. (a) SGBS cells were
transferred to cold environment after the first 4 days of initial differentiation and compared to control cells which were kept at 37°C for the duration of
the two week differentiation process. Oil Red staining was carried out as described above and the presence of stained lipid droplets at D14 was assessed.
(b) 10 day cold-exposed and control SGBS cells were co-stained with mitotracker (green) to test the abundance of mitochondria, lipidtox (red) for neutral
lipid droplets and DAPI (blue) to visualize nuclei. Single-channel images were overlayed and processed by Photoshop software. All scale bars are reported.
(c) RNA from SGBS cells, which were subjected to cold-environment for 4-6 h, was isolated using the Qiagen lipid tissue mini kit and cDNA synthesis was
carried out. Quantitative real-time PCR was performed by SYBR green detection method and expression levels are normalized for D0 baseline expression
levels. All experiments were done in triplicates and data are derived from at least three independent experiments. (* p <0.01, ** p < 0.001).
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we noticed in our study in SGBS at D14 when PLIN1 ex-
pression peaked.
Furthermore, our delineation of the expression of mito-
chondrial complexes and metabolism in these three adipo-
cyte cell lines corroborates our genomics and proteomics
results and fulfills the demand for functional assessments in
metabolic cell models. The generally increased levels ofrespiratory complexes were expectedly matched by im-
proved respiratory capacity in adipocytes relative to their
undifferentiated counterparts. We believe this is an interest-
ing finding and the reason is two-fold: firstly, the differenti-
ation process of all three cell lines was effective in
launching their oxidative capacity. This is significant in the
in vitro context because cells in culture normally shift their
metabolism towards anaerobic glycolysis, which was indeed
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ated adipocyte state. Secondly, adipose tissue is generally
regarded as metabolically slow. However, both differenti-
ated PAZ6 and D14 SGBS cells are shown to dispose of
spare respiratory capacities several fold greater than their
undifferentiated counterparts. Whether this is an intrinsic
property of the differentiated cells, an effect exclusively
dependent on the differentiation cocktail or both, remains
to be defined. It would be extremely informative to address
how the metabolic capacity of PAZ6 and SGBS compares
to that of other human tissues on a per mg of protein basis.
As for drug effects, previously reported effects of RA, T3
and forskolin/IBMX in promoting a brown adipose-like
phenotype [42] were observed in PAZ6 and SW872 adipo-
cytes in this study by means of induction of respiratory
complexes and oxidative capacity. The effect of the RA, T3
and adrenergic signaling mimetics (IBMX/forskolin) upon
glycolysis is an interesting finding. At this point we cannot
dissociate the individual effects of each compound or their
interactions with the differentiation cocktail. However, it
seems plausible that in addition to boosting lipid oxidation,
brown adipose tissue may also utilize glycolysis to support
its metabolic demands. Recently, Hao et al. described the
global expression changes is interscapular BAT (iBAT) of
cold exposed C57 mice [43]. This in-vivo experiment was
complemented with the in-vitro treatment of primary
brown adipocytes with isoproterenol for 6 hours. In both
cases, an increase in several glycolytic enzymes was de-
tected, supporting the notion that glycolysis may be a rele-
vant component in BAT cold adaptation. In line with this,
human imaging studies employing F-DG as a BAT activity
marker consistently describe increased F-DG uptake in
cold-exposed individuals. Whether the incoming glucose is
utilized anaerobically or shunted to supply uncoupled res-
piration needs to be determined. Whatever the case, this
improved capacity for glucose utilization observed in
treated PAZ6 adipocytes, provides a means whereby brown
adipocytes could scavenge excess circulating glucose, which
could be explored to improve glucose homeostasis in dia-
betic states.Conclusions
Overall, our study investigates intrinsic properties of the
unique human brown adipose cell line PAZ6, human white
SW872 adipocytes and human SGBS cells that display a
transient brown phenotype which can be further induced
by β-adrenergic stimulation through cold exposure. Even
though this behavior was shown in only one cell line and
cannot be generalized at this point, our unique study con-
tributes to the discovery of molecular gene expression pat-
terns and pathways, which are involved in the conversion
from white and brown adipocytes. This knowledge will be
of importance for translational studies aimed at increasingbrown fat depots in order to increase energy expenditure in
obese subjects with the ultimate goal of weight reduction.
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